Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 26,507 shares at $34.87 ($924K) on 2017-08-30, disclosed to the SEC on 2017-09-01.
Open-market sale of $924k ACAD by EVP AND GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |
| ACAD | SELL | 2017-07-21 | $1.1M | — | Filing → |
| ACAD | SELL | 2017-06-26 | $57K | — | Filing → |